Multinational Case Registry of Secondary Antifungal Prophylaxis

A Project of the ID Working Party of the German Society for Haematology and Oncology

Recruitment complete.





Protocol pdf-file


Participating centers


publications


Study statistics
Patient definition

Inclusion criteria --- prospective stratum
  • patients treated after October 1, 2001
  • history of proven or probable IFI
  • AML, i.e. de novo, relapse, or secondary, or ALL
  • new neutropenic phase with or without secondary prophylaxis
Inclusion criteria --- retrospective stratum
  • patients treated before October 1, 2001
  • history of proven IFI
  • new neutropenic phase with or without secondary prophylaxis
Exclusion criteria
  • history of possible IFI, but not of proven or probable IFI

IFI denotes invasive fungal infection


Queries: research @neutropen.de



last update 01.03.06